Milestone Pharmaceuticals 2024财年GAAP每股收益$(0.67)未达$(0.62)的预期,现金余额为$69.7M

财报速递
13 Mar
Milestone Pharmaceuticals 2024财年GAAP每股收益$(0.67)未达$(0.62)的预期,现金余额为$69.7M。

以上内容来自Benzinga Earnings专栏,原文如下:

Milestone Pharmaceuticals FY 2024 GAAP EPS $(0.67) Misses $(0.62) Estimate, Cash Balance Of $69.7M

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10